Zi-Chang Jia

Zi-Chang Jia

Auto-generated profile, based on publicly available information

Zi-Chang Jia

State Key Laboratory of Crop Biology, College of Life Science Shandong Agricultural University Tai'an China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2024 in Pharmacological Reviews
Verified
Journal Article
Closed access
PDF file
ZJZi-Chang Jia
Zi-Chang Jia
XYXue Yang
Xue Yang
YWYi-Kun Wu
Yi-Kun Wu
MLMin Li
Min Li
DDDebatosh Das
Debatosh Das
JWJian Wu
Jian Wu
Drug targets are specific molecules in biological tissues and body fluids that interact with drugs. Drug target discovery is a key component of drug discovery and is essential for the development of new drugs in areas such as cancer therapy and precision medicine. Traditional in vitro or in vivo target discovery methods are time-consuming and labor-intensive, limiting the pace of drug discovery. With the development of modern discovery methods, the discovery and application of various emerging technologies have greatly improved the efficiency of drug discovery, shortened the cycle time, and reduced the cost. This review provides a comprehensive overview of various emerging drug target discovery strategies, including computer-assisted approaches, drug affinity response target stability, multiomics analysis, gene editing, and nonsense-mediated mRNA degradation, and discusses the effectiveness and limitations of the various approaches, as well as their application in real cases. Through the review of the aforementioned contents, a general overview of the development of novel drug targets and disease treatment strategies will be provided, and a theoretical basis will be provided for those who are engaged in pharmaceutical science research. Significance Statement Target-based drug discovery has been the main approach to drug discovery in the pharmaceutical industry for the past three decades. Traditional drug target discovery methods based on in vivo or in vitro validation are time-consuming and costly, greatly limiting the development of new drugs. Therefore, the development and selection of new methods in the drug target discovery process is crucial.

29 July 2026 in Physiologia Plantarum
Verified
Journal Article
Closed access
LHLuobing Han
Luobing Han
ZJZichang Jia
Zichang Jia
SJShaolong Jiang
Shaolong Jiang
ZZZiyu Zhang
Ziyu Zhang
QZQingyi Zhang
Qingyi Zhang
YTYuan Tian
Yuan Tian